Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $142B | +$3.69B | 221 | 3.84% | Increased |
|
| 2 |
BlackRock
New York
| $134B | +$3.47B | 238 | 3.92% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $77.3B | -$934M | 183 | 4.43% | Reduced |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $33.5B | +$689M | 75 | 5.89% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $33.5B | +$6.59M | 151 | 2.86% | Increased |
|
| 6 |
Geode Capital Management
Boston,
Massachusetts
| $26.6B | +$1.13B | 246 | 4.07% | Increased |
|
| 7 |
T. Rowe Price Associates
Baltimore,
Maryland
| $24.4B | +$1.32B | 128 | 2.44% | Increased |
|
| 8 |
JP Morgan Chase
New York
| $23.2B | +$1.04B | 194 | 3.1% | Increased |
|
| 9 |
Northern Trust
Chicago,
Illinois
| $20.9B | -$326M | 212 | 3.88% | Reduced |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $20.5B | +$277M | 229 | 2.3% | Increased |
|
| 11 |
Capital World Investors
Los Angeles,
California
| $20.5B | -$4.27B | 25 | 3.78% | Reduced |
|
| 12 |
Capital Research Global Investors
Los Angeles,
California
| $20.2B | -$1.67B | 13 | 4.95% | Reduced |
|
| 13 |
Capital International Investors
Los Angeles,
California
| $18.9B | -$495M | 27 | 4.77% | Reduced |
|
| 14 |
Bank of New York Mellon
New York
| $18B | -$501M | 197 | 3.67% | Reduced |
|
| 15 |
Norges Bank
Oslo,
Norway
| $17.2B | -$134M | 63 | 3.93% | Reduced |
|
| 16 |
Morgan Stanley
New York
| $17.2B | +$290M | 257 | 2.52% | Increased |
|
| 17 |
BBA
Baker Bros. Advisors
New York
| $15B | +$331M | 42 | 65.11% | Increased |
|
| 18 |
Primecap Management
Pasadena,
California
| $13.3B | -$79.3M | 19 | 9.3% | Reduced |
|
| 19 |
Wells Fargo
San Francisco,
California
| $13.2B | -$314M | 233 | 2.98% | Reduced |
|
| 20 |
Franklin Resources
San Mateo,
California
| $12.5B | +$1.84B | 61 | 5.08% | Increased |
|
| 21 |
Charles Schwab
San Francisco,
California
| $11.6B | +$2.06B | 169 | 4.27% | Increased |
|
| 22 |
Nuveen
Charlotte,
North Carolina
| $11.3B | -$538M | 146 | 3.6% | Reduced |
|
| 23 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $10.5B | $0 | 7 | 11.14% | Maintained |
|
| 24 |
Ameriprise
Minneapolis,
Minnesota
| $10.2B | +$177M | 87 | 3.39% | Increased |
|
| 25 |
Legal & General Group
London,
United Kingdom
| $10.1B | -$163M | 162 | 3.77% | Reduced |
|